Abstract:
The present invention relates to a method for promoting eye health by administering to a companion animal a composition comprising at least one polyphenol selected from the group consisting of rosemary, rosemary extract, coffeic acid, coffee extract, turmeric extract, cucurmin, blueberry extract, grapeseed extract, rosemarinic acid, tea extract, and mixtures thereof.
Abstract:
The present invention relates to a composition for promoting eye health in a companion animal. The composition comprising: at least one polyphenol selected from the group consisting of rosemary, rosemary extract, coffee acid, coffee extract, turmeric extract, cucurmin, blueberry extract, grapeseed extract, rosemarinic acid, tea extract, and mixtures thereof.
Abstract:
A pet food composition having at least two carotenoids. The carotenoids can include a keto-carotenoid and at least one non-keto-carotenoid. The keto-carotenoid can include astaxanthin. The keto-carotenoid can include astaxanthin ester. The non-keto-carotenoid can include beta-carotene and/or lutein.
Abstract:
A composition including a glucose anti-metabolite and selenium. The composition can be for a companion animal. The composition can include added selenium and endogenous selenium. The composition can be a nutritionally balanced pet food composition.
Abstract:
A composition including a glucose anti-metabolite, BHA, and/or BHT. The composition can be for a companion animal. The composition can be a nutritionally balanced pet food composition.
Abstract:
A method of improving the immunity of a companion animal. The method can include administering to the companion animal a glucose anti-metabolite. The glucose anti-metabolite can be 2-deoxy-D-glucose; 5-thio-D-glucose; 3-O-methylglucose; 1,5-anhydro-D-glucitol; 2,5-anhydro-D-glucitol; 2,5-anhydro-D-mannitol; mannoheptulose; and mixtures and combinations thereof. The companion animal can be a dog or a cat. Improving the immunity can include altering the proliferative ability of T and B immune cells, and altering the relative distribution of immune cell phenotypes, for example.
Abstract:
A medical device includes a treatment module configured to apply a medical treatment and one or more storage devices storing a device identifier that identifies the medical device. The medical device also includes one or more processing devices configured to control the treatment module to apply a medical treatment, collect compliance information that reflects a patient's compliance with a treatment regimen, access the device identifier from the one or more storage devices, and send the collected compliance information with the accessed device identifier to a server system. The server system is configured to receive the compliance information and the device identifier, determine a patient identifier based on the device identifier, store the compliance information in association with the determined patient identifier, and provide access to the compliance information in response to an inquiry.
Abstract:
Disclosed are methods and apparatus for guaranteeing restoration of traffic between one or more cable modems and a backup cable modem termination system upon failure of an active cable modem termination system are disclosed. Subscriber information associated with one or more cable modems are received from an active cable modem termination system. The subscriber information includes one or more subscriber identifiers. For instance, the subscriber information may include a primary subscriber identifier that identifies a particular cable modem as well as a secondary subscriber identifier that is assigned to high priority traffic such as that being transmitted in real-time. In addition, the subscriber information may also include a scheduling type that is further used to categorize the real-time traffic, such as into voice or video traffic. The subscriber information is then prioritized in an order in which the transmission of messages between the one or more cable modems and the backup cable modem are to be restored. For instance, the subscriber information may be prioritized according to time of receipt of the subscriber information, presence of secondary subscriber identifier, and/or scheduling type. The cable modems are then polled according to this priority order.
Abstract:
A controllable reactor and a method of assembling it are disclosed. The controllable reactor (1) comprises a core structure (2) surrounded by a main winding (3), and a control winding(201) for controlling an inductance of the core structure (2), and the core structure (2) comprises a control element (20) with a control core (200) surrounded by the control winding (201). The method includes prefabrication control elements (20) with a control core (200) surrounded by the control winding (201), and stacking a plurality of prefabricated control elements (20) and uncontrolled elements (21) to form the core structure of the reactor (1), so as to simplify design, fabrication, and assembling of a controllable reactor with a transverse DC winding.